The design of our studies allows (i) to specifically inhibit calpain activity using calpastatin and (ii) for the first time, to discriminate the roles of the calpain/calpastatin system in tumor cells (growth, death, migration) and in host (angiogenesis, immune response). Here, CAST is linked to neoplasm.